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Abstract
The extraction of physiological parameters by non-invasive imaging techni-
ques such as dynamic magnetic resonance imaging (MRI) or positron emission
tomography requires a knowledge of molecular distribution and exchange be-
tween microvascularization and extravascular tissues. These phenomena not
only depend on the physicochemical characteristics of the injected molecules
but also the pathophysiological state of the targeted organ. We developed
a five-compartment physiologically based pharmacokinetic model focused on
hepatic carcinogenesis and MRI contrast agents. This model includes physical
characteristics of the contrast agent, dual specific liver supply, micro-vessel
wall properties and transport parameters that are compatible with hepato-
carcinoma development. The evolution of concentrations in the five com-
partments showed significant differences in the distribution of three molecules
(differentiated by their diameters and diffusion coefficients ranging, respec-
tively, from 0.9nm to 62nm and from 68.10−9cm2.s−1 to 47.10−7cm2.s−1) in
simulated regeneration nodules and dysplastic nodules, as well as in medium-
and poorly-differentiated hepatocarcinoma. These results are in agreement
with known vascular modifications such as arterialization that occur during
hepatocarcinogenesis. This model can be used to study the pharmacokinetics
of contrast agents and consequently to extract parameters that are characte-
ristic of the tumor development (like permeability), after fitting simulated to
in-vivo data.
KEYWORDS: PBPK model, molecule transport, liver microvascularization,
contrast agent, cancer, HepatoCellular Carcinoma, MRI, simulation
Abbreviations used: MRI, Magnetic Resonance Imaging; DCE, Dynamic Contrast-
Enhanced; PBPK, Physiologically Based PharmacoKinetic; HCC, HepatoCellu-
lar Carcinoma; CT, Computed Tomography; US, UltraSound; RN, Regenerative
Nodule; MID, Multiple Indicator Dilution; PET, Positron Emission Tomography;
Gd-DOTA, Gadolinium -(1,4,7,10-tetraazacyclododecane N,N’,N”,N”’ -tetraacetic
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acid); SPIO, SuperParamagnetic Iron Oxide; USPIO, UltraSmall Particle of Iron
Oxide; PCHIP, Piecewise Cubic Interpolating Polynomial.
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INTRODUCTION
Dynamic contrast enhanced (DCE) images are of great interest for the characte-
rization of hepatic tumors such as those giving rise to Hepatocellular Carcinoma
(HCC). Such images can be acquired by the main techniques used in routine clini-
cal studies (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) and
Ultrasound (US)) [1]. DCE imaging during and after injection of a contrast agent
improves the characterization of lesions because it allows us to access morphological
and functional features that are characteristic of the tumor development [2]. In ad-
dition to in vivo studies [3], in silico modeling is a means of studying the behavior
of different kinds of molecules. More particularly, this technique is useful to improve
our knowledge on the distribution of the numerous contrast agents already available
[4]. In addition, it can be used to predict the distribution of new agents, in order to
optimize the image acquisition (type of agent, injection method, type of acquisition
involving sequence in MRI and acquisition times). The objective of such optimiza-
tion is to strive for an early characterization of the lesion, by determining its grade
in the complex carcinogenesis process in a cirrhotic liver, which corresponds to the
progressive malignant transformation of a benign Regenerative Nodule (RN) into a
malignant tumor, HepatoCarcinoma (HCC) [5] (Fig.1). The Regenerative Nodule
is made up of normal hepatic cells, associated with an architectural disruption. Its
vascular portal and arterial supplies are similar to those of the adjacent normal
parenchyma. During the progressive malignant transformation of the nodule, we
observe a rarefaction of the portal tracts (structures containing the hepatic arte-
riole and portal venule), together with an arterial neoangiogenesis (hatched gray
region on the diagram). These new vessels have morphological and physiological
characteristics that differ from a normal hepatic arteriole (in gray on figure 1). The
portal supply of the nodule decreases progressively until it is canceled out in the
poorly-differentiated HCC (HCCp). The phenomena are slightly more complex re-
garding the arterial supply (gray zone plus the hatched gray region corresponding to
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neo-vessels): an initial decrease of flow is observed in low-grade dysplastic nodules
(DNl), which then progressively increases due to the arterial neovascularization. For
high-grade dysplastic nodules (DNh) and well-differentiated HCC (HCCw), the ar-
terial flow growth, due to neo-vessels, can fully compensate for the drop in flow of
the normal arteriole.
Distribution of solutes in the whole liver has been widely studied by multiple indi-
cator dilution (MID), wich consists in studying simultaneously several tracers with
different behavior, mostly for experimental measurements such as vascular and ex-
travascular blood volumes [6] [7] [8] [9]. Several other studies, that can be considered
as “global”, have been carried out to model the transport of molecules. For exam-
ple, we can cite a number of adaptations of the one-tissue compartment model
based on a Kety-Schmidt type approach and applied to PET images [10] [11] [12]
[13] [14] [15]. Materne et al. [16] [2] proposed a dual-input (aorta and portal vein)
one-compartmental model to quantify liver perfusion. Although this model is well
adapted to hepatic microcirculation, the approach is global since the whole liver is
considered as only one compartment. Several other global studies were performed
concerning the whole liver but still not at the microscopic scale [17] [18] [19].
In earlier work, Bert & Pinder [20] developed a three-compartment model of the
human microvascular system that integrated fluid mechanics with protein and flow
variations. Although this model simulates capillary fluid movements precisely, it
is not adapted to hepatic microvascularization because the portal supply is not
taken into account. With this aim in view, many works were applied to the liver
[22] [21] [23]. However, they do not integrate physiological or geometrical parame-
ters. In 2004, Be´zy-Wendling and Kretowski integrated a three-compartment model
of hepatic microvascularization into a macroscopic model of the hepatic vascular
system in order to simulate CT images of liver tumors [24] [25]. Although this
physiologically-based model uses several parameters such as osmotic and hydro-
static pressures to measure flows, it does not allow for variations in the permeability
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of capillaries and vessels, or changes in molecular properties.
In the present study, we propose a Physiologically Based PharmacoKinetic model
that is able to simulate the propagation of contrast agents in the small hepatic ves-
sels, while taking into account the specificity of liver dual supply (arterial and portal)
as well as the sinusoids. We incorporate the most important parameters showing
variations that characterize the tumoral stage evolution: these are mainly transport
parameters (vascular permeability, hydraulic conductivity, reflection coefficient) re-
lated to the properties of the molecule and of the vascular walls, but also include the
exchange area and pressure gradients. In the methods section, we present the phy-
siological parameters that need to be considered and describe the model in detail.
The last section is concerned with evaluation of the properties of the model through
simulation results, as well as its application to represent molecular exchanges with
three contrast agents – Gd-DOTA (Dotaremr, Guerbet, France, 0.9nm diameter
and 70× 10−7cm2.s−1 diffusion coefficient [26]), P792 blood pool agent (Gadomeli-
tol, Vistaremr, Guerbet, France, 5nm diameter and 8.4 × 10−7cm2.s−1 diffusion
coefficient [27]) and SuperParamagnetic Iron Oxide (SPIO) SHU-555-A (Resovist,
Shering, Germany, 62nm diameter and 68 × 10−9cm2.s−1 diffusion coefficient [28])
– in the case of normal liver, dysplastic nodule and differentiated hepatocellular
carcinoma.
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METHODS
The Model
We present here a five-compartment model of an hepatic lobule that fully integrates
the hepatic arteriole and the portal venule as compartments and not just as sim-
ple inputs of the model. The five compartments are then the hepatic arteriole,
the portal venule, the sinusoidal network, the hepatic venule and the interstitial
fluid. The inputs are the terminal branches of the hepatic artery and the portal
vein, which supply the hepatic lobule, considered here as the functional unit of the
liver parenchyma (Fig.2). The output is the terminal hepatic venule, supplied by a
capillary network that composes the sinusoidal compartment. These compartments
do not only communicate with each other while the molecule is propagating, since
transmembranar exchanges also exist between some compartments and the inters-
titial fluid inside the lobule. A model of these exchanges was already applied by
Kellen et al. [29] in the cardiovascular system.
An overview of our model is given in Fig.3. In this model, several pathways denoted
as k, and modelled as “holes” in the vascular walls, are considered. For example,
sinusoids are a particular type of discontinuous capillaries that exhibit large fenes-
trations (k = f), as well as small and large pores (k = sp and k = lp). Another way
occurring in tumoral tissue can be taken into account and concerns fluid transport
through endothelial cells (k = endo). On the contrary, the arteriole and venule are
assumed to be impermeable in a normal liver. All parameters used in the following
are listed in table 1.
Physiological parameters
Several parameters determine the exchanges of vascular and extravascular fluids and
molecules in a tissue. Some, such as the vascular permeability P , the hydraulic con-
ductivity L and the reflection coefficient σ, are said to be “transport” parameters.
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They depend on physicochemical properties of the molecule (size, charge, structure
and fixation) and on physiological and physicochemical properties of the vascular
wall (endothelial junctions, number of fenestrations, transendothelial ducts, conti-
nuity or discontinuity of the membrane, etc.).
Other important physiological parameters include the surface-area of exchange Ak,
related to the kst pathway, concentration gradients and pressure gradients. In the
case of small molecules, crossing of the vascular wall usually occurs by diffusion and
is assisted by concentration gradients. However, when large molecules are concerned
(bigger than fenestrations), this occurs via convection owing to pressure gradients.
Transmembranar fluid exchanges Jkf are controlled by forces that correspond to
hydrostatic (p) and osmotic (Π) pressures. Hydrostatic pressure arises from gravi-
tational forces, and decreases from the arterio-portal to the venous extremities. On
the other hand, osmotic pressure arises from solute concentration gradients, and
varies from one side of the capillary wall to the other (Fig.4). However, for the
moment, no spatial information is integrated into the model.
The filtration-based fluid movement through a vessel wall is governed by Starling’s
hypothesis [30], which proposes that this phenomenon depends on an equilibrium
between the hydrostatic and osmotic pressure gradients across the wall, as shown in
Eq.1.
Jkf = Lk{(pv − pil)− [σk(Πv − Πil)] + ΠM} (1)
The subscripts v and il stand for vessel and interstitial fluid, respectively.
ΠM defines the osmotic pressure of the immobile interstitial matrix, which is
related to the matrix osmotic pressure coefficients ψn=1,2,3, and the quantity of in-
terstitial matrix Mim (Eq.2) [29].
ΠM = ψ1Mim + ψ2M
2
im + ψ3M
3
im (2)
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The transport of molecules (solute flux Jks ) through the pores of a vessel or a
capillary membrane can be described by Patlak’s equation with separate diffusive
and convective components [30] [31], Eq.3.
Jks = Pk(Cv − Cil)
Pek
ePek − 1
+ Jkf (1− σk)Cv (3)
The Peclet number Pe, defined in Eq.4, is a dimensionless number that represents
the ratio of mass transport by convection to mass transport by diffusion:
Pek =
Jkf (1− σk)
Pk
(4)
Both transport mechanisms (solute and solvent) can be coupled, especially for
transit through pores and fenestrations.
Jf = J
endo
f + J
sp
f + J
lp
f + J
f
f (5)
Js = J
sp
s + J
lp
s + J
f
s (6)
However, for most hydrophilic solutes, when endothelial crossing is taken into
account, the only process activated is the volume flux of pure water Jendof (Eq.7),
proportionally to the transendothelial hydraulic conductivity Lendo [29].
Jendof = Lendo{(pv − pil)− [(Πv − Πil)] + ΠM} (7)
Pore model for transcapillary exchanges
Three possible pathways k = sp, lp, f are considered for the exchanges of water
and solute through the pores of the vessel membrane. Those “idealized” pores are
modeled as cylinders that permit spherical solutes to cross the membrane according
to Bean’s equations, as cited by Kellen [29]. These equations are associated with
the hydraulic conductivity Lk (Eq.8), the permeability Pk (Eq.9) and the reflection
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coefficient σk (Eq.10).
Lk = (
Ak
S∆r
)
r2k
8η
(8)
Pk = (
Ak
S∆r
)(1− αk)F (αk)D (9)
σk = 1− [1− (1− (1− αk)
2)2]G(αk) +
16
9
α2k(1− αk)
2F (αk) (10)
αk =
r
rk
(11)
S defines the vascular compartment surface-area. η is the perfusate viscosity.
The total area of the k-like pores Ak in one compartment is obtained from their
radius rk and their density dk in that compartment [30] [32]. F (αk) and G(αk)
are decreasing hydrodynamic functions defined by Curry [33]. They depend on
the molecule/pore radius ratio αk, so that, for a fixed pore radius, the diffusion
coefficient in the pore decreases as the solute molecule radius increases. This effect
results from the viscous layer of fluid at the pore walls, which retards the solute
diffusion increasingly with its radius. The relation between the radius of a molecule
and its diffusion coefficient in a medium is given by Stokes-Einstein equation (Eq.12).
D =
RT
6piNηr
(12)
where R is the gaz constant, T is the absolute temperature, N is the Avogadro
number, η is the medium viscosity and r is the molecule radius. The permeability
is controlled by the properties of the pore and the vessel or capillary (radius, area,
membrane wall thickness ∆r), as well as those of the molecule (radius r and diffusion
coefficient D).
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Model equations
Besides some findings of the MID method [6], the volume of each compartment is
assumed constant and the vessels are modeled as well-stirred compartments and
are filled with the molecule instantaneously. Otherwise, we would need to apply a
volume gradient.
The agent propagation is described by the system of differential equations given
below, where the variation of the molecular concentration C(t) in each compartment
is computed as a function of time.
Vha
dCha(t)
dt
= Q0haC
0
ha(t)− Sha ×ha Js(t)−QhaCha(t) (13)
Vpv
dCpv(t)
dt
= Q0pvC
0
pv(t)− Spv ×pv Js(t)−QpvCpv(t) (14)
Vsi
dCsi(t)
dt
= QhaCha(t) +QpvCpv(t)− Ssi ×si Js(t)−QsiCsi(t) (15)
Vil
dCil(t)
dt
= Sha ×ha Js(t) + Spv ×pv Js(t) + Shv ×hv Js(t)
+Ssi ×si Js(t)−QLCil(t) (16)
Vhv
dChv(t)
dt
= QsiCsi(t)− Shv ×hv Js(t)−QhvChv(t) (17)
The term subscripts are in concordance with each compartment initials (ha, pv,
si, il, hv, stand for hepatic arteriole, portal venule, sinusoids, interstitial liquid and
hepatic venule respectively). Based on the hypothesis assumed for the volumes and
a knowledge of the flows at the input to the model, the mass conservation law can
be applied to the flow in each compartment, while specifying that the output flow
equals the input flow (Eq.18 to Eq.21).
Qha = Q
0
ha − Sha ×ha Jf (18)
Qpv = Q
0
pv − Spv ×pv Jf (19)
Qsi = Qha +Qpv − Ssi ×si Jf (20)
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Qhv = Qsi − Shv ×hv Jf (21)
High interstitial pressures and low lymphatic outlet pressures can lead to an
evacuation of the interstitium through the lymphatics, resulting in a lymph flow QL
(Eq.22), where KL is the lymphatic conductance.
QL =


KL(pil − pL) for pil > pL
0 for pil ≤ pL
(22)
However, in our simplifications, compartments volumes are considered as cons-
tant. Fluid balance (Eq.23) thus requires that the lymphatic flow is defined as the
sum of the net transendothelial fluxes (Eq.24).
Q0ha +Q
0
pv = Qhv +QL (23)
QL = Sha ×ha Jf + Spv ×pv Jf + Ssi ×si Jf + Shv ×hv Jf (24)
Numerical method and simulation procedure
The volumes, areas and pressures of all compartments are fixed, except for the
pressures in the interstitial fluid whose values can be modified. Assuming that the
global volume of a healthy adult liver is almost 1350mL [34] and that the whole
organ is made up of approximately one million lobules, we can obtain the volume
of a functional unit. Inside one unit, the vessels are modeled as cylinders of equal
length. Therefore, the volumes of the arteriole and venule compartments depend on
their radii and lengths, whose values are given by [35] and [36], while the volumes of
interstitial and sinusoids compartments are based on the proportion of each material
in the liver (10,6% of sinusoids and 4,9% of interstitial space), as given by [37]. For
the vessels, the areas S are computed from their volumes and diameters, while the
area of the sinusoidal compartment is given by the average area of one sinusoid
12
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[38] and the total number of sinusoids in the liver [36]. Hydrostatic and osmotic
pressures in the vessels were taken from [32], while the values for the sinusoids and
the interstitial fluid are those given in [39]. In the normal case, the vessels (arterioles
and venules) are assumed to be impermeable, and consequently have no pores and
no fenestrations on their membranes.
The system (Eq.13 to Eq.17) is computed numerically under MS Visual C++ 6.0,
with an ordinary differential equation (ODE) solver based on a fourth-order Runge-
Kutta method. The molecular concentration is measured in each compartment for
different physiological parameters, and its variation plotted as a function of time.
Comparable results were obtained when programming with Matlab, as well as with
JSIM, a modeling environment developed by the National Simulation Resource for
Circulatory Mass Transport (http://nsr.bioeng.washington.edu).
In the first series of validation tests, a constant concentration (0.5mM) is chosen for
the inputs C0ha(t) and C
0
pv(t), in order to observe the steady-state behavior of the
model. The reference arterial and portal inflows are 4.16cm3.s−1 and 21.8cm3.s−1
(Table 1), respectively [16] [40]. These values are divided by the total number of
lobules to obtain the inflows in the terminal vessels, which thus form the model
inputs. Here, only the capillaries are permeable. These values can be modified in
different tests with arbitrary values. Gd-DOTA is chosen as the reference molecule.
This molecule is modeled as a simple sphere. In our model, both the radius and
diffusion coefficient of Gd-DOTA (r = 0.45nm and D = 47.e−7cm2.s−1 [26]), have
an influence on its concentration variation. In [26], the radius of Gd-DOTA was
computed from Eq.12 for a measured diffusion coefficient under given conditions.
The diffusion coefficient of the two other molecules were thus deducted from their
known radius, with the same equation parameters. After this stage of validation,
the model can be used to simulate real pathological situations, which is the main
purpose of the present approach. With this aim in view, we use the data provided
by dynamic contrast enhanced relaxometry to extract curves describing the time-
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evolution of contrast agent concentration in the terminal branches of the hepatic
artery and portal vein. Such quantitative method is described in [41]. Here, the
procedure is carried out on a sequence of successive MR images of the liver, after
a bolus injection of 0.1mmol.kg−1 dose of Gd-DOTA. Since these data are made
up only of a series of points, we require an interpolation step before solving the
differential equations system. The “PCHIP” interpolation method (Piecewise Cubic
Hermite Interpolating Polynomial [42]) is preferred to cubic spline interpolation in
this case, because of the steep slope of the aortic function.
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RESULTS AND DISCUSSION
Several tests were conducted to evaluate the coherence of the model, and also to
simulate pathological cases. In the first series of tests (Fig.5 to 7), the coherence
was verified through a steady-state study.
We first simulated variations in the inflows (Fig.5). The example given here involves
a decrease in the b) arterial and c) portal supplies. The curves on Fig.5.a) represent
the reference case: all the following “steady-state” results were obtained under the
same conditions unless notification. Variations in the amount of inflow play an im-
portant role in the compartment filling speed, as seen on Fig.5.b) and c), particularly
when the portal supply is decreased, as its value is normally much more important.
In fact, as a reference condition, the vessels (arterioles and venules) are assumed to
be impermeable, which implies, according to the mass conservation law, that all the
solute coming into the arteriole and portal venule goes to the sinusoids. Flows only
affect the speed, as illustrated on the graph showing that final concentrations in all
the compartments reach the maximum value corresponding to the injected solute
concentration. The permeability of the capillaries allows the contrast agent concen-
tration to be in equilibrium between the sinuoidal compartment and the interstitial
fluid.
In the next step, we tested the influence of each of the two parameters defining the
molecule, under normal conditions. In Fig.6 the radius is increased from a) to c).
Values given here correspond to a) rGd−DOTA, b) rP792 and c) rSHU−555−A. Results
on Fig.7 show the effect on the concentrations, of decreasing the diffusion coefficient
from a) DGd−DOTA, to c) DSHU−555−A. From the results presented on Fig.6 and 7,
we conclude that the solute concentration evolution depends strongly on the radius
and diffusion coefficient of the molecule. Indeed, an increase in the solute radius
(rGd−DOTA < rP792 < rSHU−555−A) leads to a decreased concentration in the inters-
titial fluid, due to the decreased number of molecules able to cross the membrane
of the sinusoids (Fig.6). However, this difference is not measurable on Fig.6.a) and
15
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b), where the radius was approximately multiplied by five. At this level, molecules
are all able to cross all kinds of pores rapidly. Only a decreased diffusion coefficient
in the case of P792 molecule has a real influence on the interstitial concentration
(Fig.7.b). In the case of the SPIO agent (Fig.6.c and 7.c), fenestrations are the
unique path for the molecule. Consequently, its circulation from the sinusoids to
the interstitium is more difficult. Here the radius alone already has a strong influ-
ence (Fig.6). The large size of SHU-555-A, combined to its low diffusion coefficient
leads to a decreased concentration in the interstitium. In fact, these two proper-
ties of the molecule generate opposite reactions, as they are inversely proportional.
The parameter D acts as a proportionality factor affecting the sinusoid membrane
permeability (see Eq.9), in such a way that decreasing D leads to a decrease in
the interstitial molecular concentration. The impact of varying the solute diffusion
coefficient (D) differs from that observed when varying the molecular radius. In
fact, the molecular radius is directly related to the ratio of solute to pore radius α
(Eq.11). This ratio varies inversely with the growth in permeability and osmotic
reflection coefficient (Eq.9, 10), and then rises with the solute flux (Eq.3).
In the following results (Fig.8), simulated curves are presented for the three types of
extracellular molecules (a) Gd-DOTA, b) P792, c) SHU-555-A). Gd-DOTA is cur-
rently used in clinical routine and is thus presented here as the reference molecule.
P792 was chosen as an example of a recently developped macromolecular blood pool
agent, while SHU-555-A , which has interesting because very different characteris-
tics, has been proved useful in the detection of HCC [28]. Different stages in the
development of a HCC (HepatoCellular Carcinoma) in the liver were simulated and
the main results are presented in Figs.8.2 to 8.4. At the outset, the liver is characte-
rized by an initial high arterial concentration peak (green curve), followed by transit
of the molecule through the portal venule (red curve). In a healthy liver (Fig.8.1),
sinusoids (blue curve) are mostly supplied by the portal venule, and communicate
directly with the hepatic venule (yellow curve). The molecular concentration in
16
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the sinusoids then becomes closely similar to the portal concentration, except at
the outset when only the arteriole is supplied. Sinusoidal pores and fenestrations
allow solute communication with the interstitial fluid (black curve), where the con-
centration decreases as the molecule size increases and consequently as its diffusion
coefficient decreases, especially for larger molecules as SPIO (Fig.8.1.c).
The high-grade dysplastic nodule (DNh) is characterized by a decrease in the ar-
terial and portal supply, an increasing permeability of the vessels (arterioles and
venules) – some small and large pores appear on the vessel membrane but no fe-
nestrations are present – and a decreased number of fenestrations in the capillary
membrane (Fig.8.2). One direct consequence of weaker portal and arterial inflows is
that concentrations in sinusoids, interstitial fluid and hepatic venule are lower than
those obtained in the “normal situation”. The behavior of both Gd-DOTA and
P792 molecules is very similar (Fig.8.2.a) and b)) while the area of communication
with the interstitial fluid has more effect on SHU-555-A (Fig.8.2.c)).
In the case of the medium-differentiated carninoma (HCCm), neoangiogenesis which
corresponds to the birth of new vessels on the arterial tree, leads to an increase of
the arterial supply inversely with the portal one in the tumoral region (see Fig.1).
Fenestrations disappear from the sinusoids (Fig.8.3), according to a capillarization
phenomenon, also observed in liver cirrhosis [43] [44]. The disappearance of fe-
nestrated pores at this stage of the pathology will result in an increased sinusoidal
concentration of the solute, which encounters difficulties in crossing the capillary
wall, and a decreased concentration in the interstitial fluid, where it is almost equal
to zero for larger molecules (Fig.8.3.b)). This curve normally reaches the equili-
brium value but few minutes later. However, it is impossible for SPIO molecule to
penetrate the interstitial fluid since it’s diameter is higher than those of the pores
(Fig.8.3.c)). Globally, as the portal supply decreases, i.e. as the tumor malignancy
becomes more important, the hepatic circulatory system tends to “arterialize”, as
illustrated by the curves on Fig.8.3 and 8.4 where the maxima approach the arterial
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peak.
A significant growth in the arterial supply, combined with an inhibition of the por-
tal supply, is more particularly characteristic of a poorly-differentiated carcinoma
(HCCp) (Fig.8.4). The arterialization thus becomes even more evident. The pre-
sence of small and large pores in arterioles and venules allows some exchanges with
the interstitial fluid. This typical effect is expressed here by a lower but non-zero
molecular concentration in the portal venule. As a result, sinusoidal and hence he-
patic venule concentrations as well, even if mostly dependent on the arterial supply
in this case, are also affected by the portal supply, at least with the Gd-DOTA
molecule (Fig.8.4.a)). The same observations as for HCCm curves can be made for
the blood pool (P792) and SPIO (SHU-555-A) agents. In fact, the input profiles
used in our application (with an early arterial peak) are “Gd-DOTA-specific”. More
realistic results for larger molecules such as USPIO and SPIO, which have a longer
residence time in the vessels, will necessitate to take into account well corresponding
profiles in future studies. Moreover, the diffusion phenomena in the large vessels un-
til the micro-vessels would tend to flatten concentration profiles used as inputs in
our compartmental model. Injection profiles at the entry of the aorta should then
be different than those at the level of the arteriole.
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CONCLUSION AND FUTURE PROSPECTS
A model of molecular exchanges in hepatic microvascularization, integrating func-
tional parameters such as permeability, flux or fenestrations number and size, that
vary with the tumor development, is presented in this paper. The coherence of
this model was verified under particular conditions of simulation (steady-state) for
three kinds of contrast agent molecule. Even if the proton relaxivities r1 and r2
of a contrast agent are influenced by several parameters (including the contrast
agent composition and in the case of Gadolinium, the interactions of the Gd(III)
ion with the inner sphere and outer sphere water protons), we decided to consider
these parameters constant in our study, and to characterize the molecule by its main
physicochemical properties. Modification of tissue water (bound vs. free water ratio,
correlation times, etc) during a liver disease evolution is also considered as constant
in the model.
Moreover, the model was applied to the modeling of different stages of liver carcino-
genesis, from healthy case to Hepatocellular Carcinoma. The simulated concentra-
tion vs. time curves appear to be in agreement with known modifications in the liver
related to hepatocarcinogenesis, as seen, for example, in arterialization phenomena.
However, before using our model to predict the behavior of new contrast agents, an
other validation step will have to be done, by comparing our results to in-vivo data.
Nevertheless, these data are difficult to obtain in the human liver: only few research
teams have published experimental curves [45]. On the contrary, more studies have
been led on the rat or on the rabbit [46] [47]. Further modifications are also en-
visaged to integrate hepatic cell and bile duct compartments in the model. Such
evolution should allow us to simulate excretion and active transport, and thus lead
to a more realistic and generic type of model. It would also be interesting to add
a phagocyte compartment for contrast agents (such as USPIO or SPIO molecules)
that are associated with phagocytosis.
Modeling transport processes is of great interest since we intend to use this model,
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not only to test the behavior of new contrast agents for MRI and other imaging
techniques, but also to simulate the pharmacokinetics of therapeutic molecules in
the hepatic parenchyma.
Furthermore, one of our goals in future work is to couple this pharmacokinetic model
with a macroscopic model of the liver [48] [24], in order to simulate tumor images
and determine image parameters related to tumor development. In this future study
on MR simulation, we will take into account not only the MR sequence parameters
(TR, TE, flip angle, etc) but also r1 and r2 as the major NMR characteristics of the
contrast agent.
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Captions
Figure 1: Evolution of blood supply during hepatocarcinogenesis (RN : Regenerative
Nodule, DNl,h : low, high grade Dysplastic Nodule, HCCw,m,p : well, moderate,
and poorly differentiated HCC) from [5].
Figure 2: Structure of the hepatic lobule.
Figure 3: Five compartments model of the hepatic microvascular transport of
molecules. Symbols: see table 1. Indexes ha, pv, si, hv and il represent the hepatic
arteriole, portal venule, sinusoids, hepatic venule and interstitial fluid compartments
respectively; L represents the lymph.
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Figure 4: Osmosis: two solutions of different concentration are open at the at-
mosphere but separated by a semi-permeable membrane which is permeable to the
smaller solvent molecules but not to the larger solute molecules. The solvent will
thus tend to diffuse across the membrane from the less concentrated to the more
concentrated solution. The osmotic pressure in the solution contained in the cham-
ber A is equal to the equilibrium pressure difference across the membrane.
Figure 5: Evolution of a molecule concentration vs. time, in the five compart-
ments of the compartmental model. Influence of the inflows: a) Reference case:
Q0ha = 4.16cm
3.s−1 and Q0pv = 21.8cm
3.s−1, permeable sinusoids (rsp = 6nm,
dsp = 12.5nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2; rf = 75nm, df =
11nbf .µm
−2) [30][32] and impermeable vessels. Molecule Gd-DOTA: r = 0.9nm
and D = 70.e−7cm2.s−1. b) Qha0 is decreased compared to a: Q0ha = 2cm
3.s−1 and
Q0pv = 21.8cm
3.s−1. c) Qpv0 is decreased compared to a: Q0ha = 4.16cm
3.s−1 and
Q0pv = 10cm
3.s−1. (Note: Sinusoids, hepatic venule and interstitial fluid concentra-
tion curves are superposed).
Figure 6: Evolution of a molecule concentration vs. time, in the five compart-
ments of the compartmental model. Influence of the molecule radius: a)
Reference case: Q0ha = 4.16cm
3.s−1 and Q0pv = 21.8cm
3.s−1, permeable sinu-
soids (rsp = 6nm, dsp = 12.5nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2;
rf = 75nm, df = 11nbf .µm
−2) [30][32] and impermeable vessels. Molecule Gd-
DOTA: r = 0.9nm and D = 47.e−7cm2.s−1. b) r = 2.5nm. c) r = 31nm.
Figure 7: Evolution of a molecule concentration vs. time, in the five compartments
of the compartmental model. Influence of the molecule diffusion coefficient:
a) Reference case: Q0ha = 4.16cm
3.s−1 and Q0pv = 21.8cm
3.s−1, permeable sinusoids
(rsp = 6nm, dsp = 12.5nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2; rf = 75nm,
df = 11nbf .µm
−2) [30][32] and impermeable vessels. Molecule Gd-DOTA: r =
0.9nm and D = 47.e−7cm2.s−1. b) D = 8.4e−7cm2.s−1. c) D = 68e−9cm2.s−1.
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Figure 8: Evolution of a molecule concentration vs. time, in the five compart-
ments of the compartmental model. 8.1. Normal liver (Reference case):
Q0ha = 4.16cm
3.s−1 and Q0pv = 21.8cm
3.s−1, permeable sinusoids (rsp = 6nm,
dsp = 12.5nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2; rf = 75nm, df =
11nbf .µm
−2) [30][32] and impermeable vessels. 8.2. Dysplastic Nodule (DNh):
Q0ha = 2.74cm
3.s−1 and Q0pv = 9.54cm
3.s−1, permeable sinusoids (rsp = 6nm, dsp =
12.5nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2; rf = 75nm, df = 5nbf .µm
−2)
and vessels (rsp = 6nm, dsp = 6nbsp.µm
−2; rlp = 27.5nm, dlp = 1/20nblp.µm
−2).
Both sides: a) Molecule Gd-DOTA: r = 0.45nm and D = 47.e−7cm2.s−1 (Note:
hepatic venule, sinusoids and interstitium concentration curves are almost super-
posed. b) Molecule P792: r = 2.5nm and D = 8.4e−7cm2.s−1. c) Molecule SHU-
555-A: r = 31nm and D = 68.e−9cm2.s−1 (Note: hepatic venule and sinusoids
concentration curves are superposed on b and c).
Figure 8 – continued : 8.3. Medium Differentiated Hepatocellular Carcinoma
(HCCm): Q0ha = 6.24cm
3.s−1 and Q0pv = 4.09cm
3.s−1, no fenestrations in sinusoids
(rsp = 6nm, dsp = 12.5nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2) and perme-
able vessels (rsp = 6nm, dsp = 6nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2).
8.4. Poorly Differentiated Hepatocellular Carcinoma (HCCp): Q0ha =
10.15cm3.s−1 and Q0pv = 0cm
3.s−1 no fenestrations in sinusoids (rsp = 6nm,
dsp = 12.5nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2) and permeable vessels
(rsp = 6nm, dsp = 6nbsp.µm
−2; rlp = 27.5nm, dlp = 0.05nblp.µm
−2). Both sides:
a) Molecule Gd-DOTA: r = 0.45nm and D = 47.e−7cm2.s−1. b) Molecule P792:
r = 2.5nm and D = 8.4e−7cm2.s−1. c) Molecule SHU-555-A: r = 31nm and
D = 68e−9cm2.s−1. (Note: hepatic venule and sinusoids concentration curves are
superposed).
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Definition Value and Unit Reference
C0
ha
Initial concentration in hepatic artery 0.5mM depends on the injection profile
C0pv Initial concentration in portal vein 0.5mM depends on the injection profile
Q0
ha
Arterial inflow 4.16cm3.s−1 [16][40]
Q0pv Portal inflow 21.8cm
3.s−1 [16][40]
r Molecule radius 0.45nm [26]
D Molecule diffusion coefficient 70× 10−7cm2.s−1 [26]
rha Hepatic arteriole radius 6µm [35]
rpv Portal venule radius 17.5µm [35]
rhv Hepatic venule radius 33µm [35]
lha,pv,hv Arteriole, venule length 4mm [36]
Vha ha compartment Volume 0.45× 10
−6cm3 [35][36]
Vpv pv compartment Volume 3.84× 10−6cm3 [35][36]
Vsi si compartment Volume 143× 10
−6cm3 [37]
Vil il compartment Volume 66× 10
−6cm3 [37]
Vhv hv compartment Volume 13.6× 10
−6cm3 [35][36]
Sha ha compartment Area 15× 10
−4cm2 [35][36]
Spv pv compartment Area 44× 10−4cm2 [35][36]
Ssi si compartment Area 28.6× 10
−4cm2 [38][36]
Shv hv compartment Area 83× 10
−4cm2 [35]
pha Hydrostatic pressure in the arteriole 16mmHg [32]
ppv,hv Hydrostatic pressure in the venule 5mmHg [32]
psi Hydrostatic pressure in the capillary 20mmHg [39]
pil Hydrostatic pressure in the interstitial fluid −3mmHg [39]
Πv Osmotic pressure in the vessel or capillary 28mmHg [39]
Πil Osmotic pressure in the interstitial fluid 8mmHg [39]
∆rha Arteriole wall thickness 6µm arbitrary value
∆rpv,hv Venule wall thickness 1µm arbitrary value
∆rsi Capillary wall thickness 0.5µm arbitrary value
η Perfusate viscosity (37◦) 0.007g.cm−1.s−1 [29]
rsp Small pore radius 6nm [30]
rlp Large pore radius 27.5nm [30]
rf Fenestration radius 75nm [32]
dsp Small pore density 12.5nbsp.µm−2 [30]
dlp Large pore density 0.05nblp.µm
−2 [30]
df Fenestration density 11nbf .µm
−2 [32]
Table 1: Terminology and parameter values
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Definition Value and Unit Reference
α Ratio of solute radius to pore radius 0-1 (dimensionless) computed from Eq.11
Pe Pe´clet number 0-2 (dimensionless) computed from Eq.4
ΠM Osmotic pressure of immobile interstitial matrix mmHg computed from Eq.2
Mim Quantity of interstitial matrix proteins 0.05g.mL
−1 [29]
ψi Matrix osmotic pressure coefficients ψ1 = 13.5 [29]
ψ2 = 2320
ψ3 = 1.54× 105
iJ
k
s Solute flux through the k
st path
from the vessel i to the interstitial fluid mmol.cm−2.s−1 computed from Eq.3
iJ
k
f
Fluid flux through the kst path
from the vessel i to the interstitial fluid cm.s−1 computed from Eq.1
Ak Exchange area related to the k
st path cm2 computed from (Πr2
k
dkS)
Lk Hydraulic conductivity related to the k
st path cm.s−1.mmHg−1 computed from Eq.8
Lendo Transendothelial hydraulic conductivity 1.4× 10
−8cm.s−1.mmHg−1 [29]
Pk Permeability through to the k
st path cm.s−1 computed from Eq.9
σk Osmotic reflection coefficient through the k
st path dimensionless computed from Eq.10
R Gaz constant 8.33SI
T Absolute temperature 300◦K
N Avogadro number 6.1023mole−1
Cha Concentration in hepatic arteriole mM
Cpv Concentration in portal venule mM
Csi Concentration in sinusoids mM
Cil Concentration in interstitial fluid mM
Chv Concentration in hepatic venule mM
Qha Flow in the hepatic arteriole cm
3.s−1
Qpv Flow in the portal venule cm3.s−1
Qsi Flow in the sinusoids cm
3.s−1
Qhv Flow in the hepatic venule cm
3.s−1
QL Lymph flow cm
3.s−1
– Continued –
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